The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.6M data for 1.1M Compounds and 8.10K Targets. Of those, 1,205K data for 557K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to you in 2022, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.EBI
Indiana University School of Medicine
Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs.EBI
Indiana University School of Medicine
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.EBI
Indiana University School of Medicine
Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections.EBI
Indiana University School of Medicine
Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.EBI
Indiana University
GroEL/ES inhibitors as potential antibiotics.EBI
Indiana University
A biochemical screen for GroEL/GroES inhibitors.EBI
Indiana University
Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.EBI
Indiana University School of Medicine
Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA).EBI
Indiana University School of Medicine